Press
Investors
Careers
Contact
Solutions
Products
Company
Sustainability
Press Release
Home
>
Press
>
Press Release
>
Solutions
Automotive and eMobility
Banking and Retail
Chemical and Natural Resources
Commercial and Industrial Buildings
Data Centers
Electronics
Food and Beverage
Healthcare
Logistics and Warehouse
Machinery
Power and Grid
View all
Products
Components
Power and System
Fans and Thermal Management
Mobility
Industrial Automation
Building Automation
Data Center
Telecom Infrastructure
Energy Infrastructure
Biomedical
Display and Visualization
Consumer Brands
Company
About Delta
Our Businesses
Executives
Innovation
Insights & Stories
Milestones & Awards
Global Operations
Investors
Chairman's Statement
Financials
Corporate Governance
General Shareholders' Meeting
Analyst Meeting
Contact
Material Information of overseas exchangeable bonds
Service Support
Download Center
FAQ
Delta’s Sales and Purchase T&Cs
Product Cybersecurity Vulnerability Management Policy
en-US
Contact Us
Delta’s Board of Directors Approves the Acquisition of ACT Genomics to Strengthen its Portfolio of Healthcare Solutions
06/18/2025
Category:
Corporate
Investor Services
Related News
Corporate
|
ESG
|
01/05/2026
Delta Recognized as One of Taiwan’s Top 5 Best Global Brands, Achieving Record High Brand Value with Superior 30% YoY Growth
Corporate
|
Investor Services
|
12/10/2025
Delta Electronics’ Consolidated Sales Revenues for November 2025 Totaled NT$50,543 Million
Corporate
|
Investor Services
|
12/01/2025
Delta and Subsidiary VIVOTEK Agree on Cash-for-Share Exchange Proposal for Delta to Acquire 100% Stake in VIVOTEK
Related News
Contact Us
Have a question? We'd love to hear from you.
Inquiry
Press Center - Delta’s Board of Directors Approves the Acquisition of ACT Genomics to Strengthen its Portfolio of Healthcare Solutions - Delta
